EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS
Clinical trials for EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS trials appear
Sign up with your email to follow new studies for EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Hope for kids with tough TB: new drug combo under study
Disease control Recruiting nowThis study is testing a medicine called bedaquiline, given together with other TB drugs, in children and teens (from birth to under 18 years) who have multidrug-resistant tuberculosis (MDR-TB) of the lungs. The goal is to see how safe the drug is, how the body processes it, and w…
Matched conditions: EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 17, 2026 12:05 UTC
-
TB study aims to unlock secrets of the disease
Knowledge-focused Recruiting nowThis study follows 150 people with active or latent tuberculosis (TB) to collect blood, sputum, and tissue samples. The goal is to better understand how TB behaves in the body and how the immune system responds. Participants receive standard TB treatment as part of the study, but…
Matched conditions: EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 24, 2026 04:47 UTC